Muthusamy Shanmugam's Net Worth
$6.16 Million
Who is Muthusamy Shanmugam?
Muthusamy Shanmugam has an estimated net worth of $6.16 Million. This is based on reported shares in ANI PHARMACEUTICALS INC.
SEC CIK
Muthusamy Shanmugam's CIK is 0001870913
Past Insider Trading and Trends
2023 was Muthusamy Shanmugam's most active year for acquiring shares with 2 total transactions. Muthusamy Shanmugam's most active month to acquire stocks was the month of January. 2023 was Muthusamy Shanmugam's most active year for disposing of shares, totalling 3 transactions. Muthusamy Shanmugam's most active month to dispose stocks was the month of May. 2022 saw Muthusamy Shanmugam paying a total of $138,251.50 for 5,000 shares, this is the most they've acquired in one year. In 2023 Muthusamy Shanmugam cashed out on 40,000 shares for a total of $2,070,011.86, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ANI PHARMACEUTICALS INC (ANIP) Snapshot price: $60.51
HEAD OF R&D, COO-NOVITIUM OPS
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.43% | -2.74K |
$62.00 | -$170,066.00 | 632.62K |
Scheduled
|
Jul 18
| ||
Form 4
| -6.92% | -47.26K |
$63.73 | -$3,011,592.12 | 635.36K |
Scheduled
|
Jul 15 - Jul 17
| ||
Form 4
| -2.85% | -20.00K |
$58.90 | -$1,178,000.00 | 682.62K |
Scheduled
|
Jun 21
| ||
Form 4
| -4.09% | -30.00K |
$60.59 | -$1,817,662.60 | 702.62K |
Scheduled
|
Jun 17 - Jun 20
| ||
Form 4
| -1.72% | -12.86K |
$61.81 | -$794,567.55 | 732.62K |
Scheduled
|
May 20
| ||
Form 4
| -4.75% | -37.15K |
$64.37 | -$2,391,120.80 | 745.48K |
Scheduled
|
May 15 - May 17
| ||
Form 4
| -3.36% | -27.23K |
$65.10 | -$1,772,729.07 | 782.62K |
Scheduled
|
Apr 18 - Apr 19
| ||
Form 4
| -2.73% | -22.77K |
$65.91 | -$1,500,589.42 | 809.85K |
Scheduled
|
Apr 15 - Apr 17
| ||
Form 4
| -1.19% | -10.00K |
$67.17 | -$671,700.00 | 832.62K |
Scheduled
|
Mar 8
| ||
Form 4
| -4.53% | -40.00K |
$65.77 | -$2,630,863.64 | 842.62K |
Scheduled
|
Mar 5 - Mar 7
| ||
Form 4
| -1.61% | -1.12K |
$67.67 | -$75,925.74 | 68.65K |
Feb 29
| |||
Form 4
| +47.18% | 22.37K |
—
|
—
| 69.77K |
Feb 14
| |||
Form 4
| -2.78% | -25.22K |
$56.17 | -$1,416,466.08 | 882.62K |
Scheduled
|
Jan 19 - Jan 23
| ||
Form 4
| -2.66% | -24.78K |
$55.29 | -$1,370,305.20 | 907.84K |
Scheduled
|
Jan 16 - Jan 18
| ||
Form 4
| -5.09% | -50.00K |
$52.55 | -$2,627,250.00 | 932.62K |
Scheduled
|
Dec 15 - Dec 19
| ||
Form 4
| -1.31% | -13.00K |
$51.00 | -$663,000.00 | 982.62K |
Scheduled
|
Nov 17
| ||
Form 4/A
| -3.58% | -37.00K |
$53.00 | -$1,961,147.61 | 1M |
Scheduled
|
Nov 14 - Nov 16
| ||
Form 4
| -3.50% | -36.19K |
$53.00 | -$1,918,079.91 | 1M |
Scheduled
|
Nov 14 - Nov 16
| ||
Form 4
| -2.36% | -25.00K |
$57.75 | -$1,443,868.50 | 1.03M |
Scheduled
|
Oct 17 - Oct 19
| ||
Form 4
| -2.31% | -25.00K |
$57.96 | -$1,449,035.99 | 1.06M |
Scheduled
|
Oct 13 - Oct 16
| ||
Form 4
| -4.41% | -50.00K |
$61.81 | -$3,090,616.61 | 1.08M |
Sep 15 - Sep 19
| |||
Form 4
| -4.23% | -50.00K |
$63.22 | -$3,160,750.00 | 1.13M |
Aug 28 - Aug 29
| |||
Form 4
| -4.06% | -50.00K |
$61.35 | -$3,067,449.50 | 1.18M |
Aug 14 - Aug 15
| |||
Form 4
| -1.87% | -23.47K |
$52.02 | -$1,220,844.12 | 1.23M |
Jul 19 - Jul 21
| |||
Form 4
| -2.07% | -26.53K |
$51.02 | -$1,353,598.86 | 1.26M |
Jul 14 - Jul 18
| |||
Form 4/A
| -3.75% | -50.00K |
$51.70 | -$2,584,911.86 | 1.28M |
Jun 20 - Jun 23
| |||
Form 4
| -84.38% | -40.00K |
$51.75 | -$2,070,011.86 | 7.41K |
Jun 20 - Jun 22
| |||
Form 4
| +156.81% | 28.95K |
—
|
—
| 47.41K |
Feb 28
| |||
Form 4
| +74.29% | 10K |
$27.65 | $276,503.00 | 23.46K |
Mar 17
| |||
Form 4
|
∞
| 1.35M |
—
|
—
| 1.35M |
Nov 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||